Skip to content
Risperdal
Active ingredient: Risperidone

Risperdal

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from $ 312.00, free express delivery from $ 468.00

Secure Payments
Track your order
Best price guarantee

Risperdal tablets help regulate dopamine and serotonin signalling in the brain. Treatment is prescribed individually according to age, other medicines, health conditions, and response.

Overview

Risperidone, the active ingredient of Risperdal, is an atypical antipsychotic used for schizophrenia, bipolar disorder, and irritability associated with autistic disorder.

Dosage and administration

Risperdal is supplied as tablets for oral administration. The prescriber selects the individual dose after considering the diagnosis, age, kidney function, liver function, other medicines, previous response, and sensitivity to adverse effects.

The dose is decided individually, taking age, other medicines, and health conditions into account. Dose changes are usually gradual rather than frequent or improvised.

  • Swallow the tablet exactly as prescribed.
  • Take it at a consistent time when possible.
  • Do not change the amount because symptoms improve or worsen.
  • Do not stop treatment suddenly unless a clinician gives a specific plan.
  • If a dose is missed, take it when remembered unless the next scheduled dose is close; do not double the next dose.

Exact strength selection and titration require an individual prescription. Older adults and people with kidney impairment may need lower starting doses or slower adjustments.

Do not crush, split, or chew a tablet unless the prescribing instructions specifically allow it. Altering a tablet can make administration inaccurate and may be unsuitable for the particular formulation.

The injection requires a planned clinical schedule, preparation by qualified staff, and monitoring of symptom control and adverse effects. Long-acting treatment can help some patients who have difficulty taking daily tablets consistently, but it requires reliable attendance for scheduled injections.

The prescriber may use oral risperidone before or during the transition to a long-acting formulation, depending on the treatment plan. The exact transition method depends on previous treatment, tolerability, and clinical response.

Formulation

The product-specific active ingredient is risperidone. Risperdal tablets are an oral form, while RISPERDAL CONSTA is a separate long-acting intramuscular formulation used in specialist psychiatric care.

How it affects the body

Risperidone is an atypical antipsychotic because its receptor profile differs from that of older typical antipsychotic drugs. It blocks dopamine D2 receptors and serotonin 5-HT2A receptors in the central nervous system. This combination influences the pathways involved in perception, thought, mood, and behavioural control.

Dopamine D2 antagonism is closely linked to the reduction of hallucinations and delusions. Serotonin 5-HT2A antagonism may influence mood, anxiety, and movement-related tolerability. The same dopamine effect can also contribute to extrapyramidal symptoms, increased prolactin, and emotional or physical slowing in some patients.

Risperidone is metabolised mainly through CYP2D6, with additional involvement from CYP3A4. Medicines that inhibit or induce these enzymes can change risperidone exposure. The Health Canada product information and the EMA pharmacological profile describe these interactions as clinically relevant when treatment is adjusted or combined with other medicines [2].

A new internal tremor, jaw stiffness, pacing, or an inability to sit still should be reported early. Patients sometimes describe these symptoms as anxiety, yet they may represent medication-related movement effects.

Therapeutic indications

Risperdal is the brand name associated with risperidone, an atypical antipsychotic. It is prescribed for schizophrenia and selected bipolar disorder symptoms, and it may be used for irritability associated with autistic disorder when clinically appropriate. Risperidone can reduce hallucinations, delusions, severe agitation, disorganised thinking, and mood instability linked to these conditions [1].

The medicine is intended for ongoing psychiatric treatment rather than occasional self-treatment. Its benefits may develop gradually, while some unwanted effects, such as sleepiness or restlessness, can appear earlier.

Role in Schizophrenia Management

Schizophrenia can involve hallucinations, fixed false beliefs, confused thought patterns, social withdrawal, and changes in motivation. Risperidone reduces dopamine D2 receptor signalling and also affects serotonin 5-HT2A receptors, which can help lessen psychotic symptoms while supporting mood and behavioural stability.

Doctors may continue treatment after symptoms improve because stopping an antipsychotic abruptly can increase the chance of relapse. The selected dose is decided individually, taking age, other medicines, and health conditions into account.

Keep a simple record of sleep, agitation, unusual movements, appetite, and symptom changes during the first weeks. These details give the prescriber more useful information than relying on memory during an appointment.

Risperidone may also be prescribed in bipolar disorder, especially when manic symptoms include extreme energy, reduced need for sleep, impulsive behaviour, irritability, or racing thoughts. In autistic disorder, treatment focuses on severe irritability, aggression, tantrums, or self-injurious behaviour.

Common mistakes

Several mistakes can make risperidone treatment appear unsuccessful:

  • Stopping tablets after the first improvement.
  • Doubling the next dose after a missed tablet.
  • Treating akathisia as ordinary anxiety and not reporting it.
  • Adding alcohol, sleeping tablets, or sedating antihistamines without review.
  • Ignoring gradual weight gain or changes in thirst and urination.
  • Driving before knowing whether drowsiness or slowed reactions occur.
  • Using leftover tablets for a different episode of agitation.
  • Missing follow-up appointments needed for movement, metabolic, or cardiovascular monitoring.

One subtle problem is confusing emotional blunting with symptom control. A person may feel less distressed but also unusually slowed, detached, or unmotivated. That distinction is clinically useful and should be described plainly.

Reasons not to use it

  • Cardiovascular disease, low blood pressure, fainting, or a history of heart rhythm problems.
  • Kidney impairment, because risperidone exposure may increase.
  • Liver impairment, which can affect medicine handling.
  • Epilepsy or a history of seizures.
  • Parkinsonism or Lewy body dementia, where sensitivity to antipsychotic effects may be greater.
  • Diabetes, obesity, or a history of significant metabolic problems.
  • Older age, frailty, falls, or dehydration.
  • Pregnancy or breastfeeding.
  • A history of blood clots or prolonged immobility.

Elderly patients with dementia-related psychosis have an increased risk of cerebrovascular events and death during treatment with antipsychotic drugs. Risperidone is not used routinely for this situation unless a specialist determines that the potential benefit justifies the risk.

When this is not for you

Talk to a clinician before using Risperdal if you have heart or blood-pressure problems, kidney or liver disease, seizures, Parkinsonism, dementia-related psychosis, diabetes, obesity, a history of blood clots, or are pregnant or breastfeeding. Be especially cautious if you are older, frail, dehydrated, or take medicines that cause drowsiness or affect heart rhythm.

Possible side effects

Common adverse effects of risperidone include sleepiness, dizziness, headache, increased appetite, weight gain, constipation, nausea, dry mouth, and fatigue. Some patients experience restlessness or difficulty sitting still, especially after starting treatment or increasing the dose.

Risperidone may raise prolactin. Possible effects include breast tenderness, breast enlargement, milk production unrelated to breastfeeding, menstrual changes, reduced libido, erectile difficulties, or fertility changes. These effects can occur without obvious physical warning signs, so reporting them helps the prescriber decide whether monitoring or adjustment is needed.

Extrapyramidal symptoms, or EPS, are drug-related movement problems. They can include:

  • Inner restlessness and pacing, called akathisia.
  • Muscle stiffness or slowed movement.
  • Tremor resembling Parkinson’s disease.
  • Sudden muscle spasms affecting the neck, eyes, jaw, or tongue.
  • Repetitive lip, tongue, or facial movements after longer exposure.

Serious reactions require urgent medical attention. Seek urgent care for high fever with severe stiffness or confusion, fainting, a seizure, severe allergic swelling, uncontrolled movements, severe difficulty swallowing, or sudden weakness affecting one side of the body. Neuroleptic malignant syndrome is rare but life-threatening and involves fever, marked rigidity, altered mental status, and autonomic instability.

Risperidone can cause orthostatic hypotension, meaning blood pressure falls when standing. This may lead to dizziness or falls, especially in older adults or people taking blood-pressure medicines.

Stand up slowly after sitting or lying down, especially during the first days of treatment. If dizziness causes a fall, fainting, or repeated near-fainting, the prescriber should be contacted promptly.

Weight and metabolic changes can develop gradually rather than during the first few days. Periodic monitoring of weight, blood glucose, and lipids may be appropriate, especially when treatment continues for months.

Alcohol, sleeping medicines, opioid analgesics, sedating antihistamines, and other central nervous system depressants can intensify drowsiness, impaired coordination, and slowed breathing. Combining several sedating medicines is especially concerning in older adults.

Medicines that can prolong the QT interval may increase the risk of an abnormal heart rhythm when combined with risperidone. Examples include some antiarrhythmics and selected antipsychotic or antidepressant medicines. Thioridazine, pimozide, and certain phenothiazines require specialist review rather than casual combination.

Metoclopramide and prochlorperazine can add to movement-related adverse effects because they also influence dopamine pathways. Combining dopamine-blocking medicines may increase the risk of dystonia, parkinsonism, akathisia, and tardive dyskinesia.

Carbamazepine and other enzyme inducers may lower risperidone concentrations. Fluoxetine, paroxetine, and some other CYP2D6 inhibitors may increase exposure to the active metabolite or alter the balance between risperidone and its metabolite. Sertraline can require review when used with risperidone, especially at higher doses or when other interacting medicines are present.

Give the prescriber a complete list of prescription medicines, non-prescription products, sleep aids, and recreational substances. A medicine added for nausea or insomnia can sometimes worsen risperidone-related movement or sedation effects.

Do not add thioridazine, pimozide, metoclopramide, prochlorperazine, or another antipsychotic without a specific prescribing plan.

Comparison

Risperdal is a brand of risperidone. Generic risperidone contains the same active pharmaceutical ingredient and is designed to provide the same principal pharmacological effect when approved for the same use and administered at an equivalent dose.

Inactive ingredients, tablet appearance, and manufacturing details can differ between products. Those differences may matter to a person with a specific allergy or intolerance, but they do not change the identity of the active ingredient.

The choice between a brand formulation and a generic formulation should account for the prescribed product, treatment continuity, tolerability, and clinical monitoring. Switching products should be documented so that any change in symptoms or adverse effects can be interpreted accurately.

What doctors say

In clinical practice, psychiatrists usually judge risperidone by symptom reduction, daily functioning, sleep pattern, movement symptoms, weight, and metabolic markers rather than by one isolated good or bad day. Improvement in agitation may appear before full control of delusions or hallucinations.

A doctor would usually want treatment decisions to be based on a pattern over time. Dose increases made too quickly can produce avoidable sedation, stiffness, restlessness, or dizziness. Dose reductions made suddenly can allow symptoms to return.

The practical goal is the lowest dose that maintains meaningful symptom control with tolerable adverse effects. That balance can change when kidney function, body weight, smoking status, interacting medicines, or other health conditions change. The clinician should review symptom control at follow-up visits. Weight, glucose, lipids, blood pressure, and movement symptoms may need periodic checks. Kidney and liver results can influence treatment decisions. Patients should report new or worsening adverse effects promptly. Shared decisions can support continued treatment when benefits outweigh harms.

Comparison

Abilify

Active ingredient: Aripiprazole
10mg 15mg 20mg 5mg
From $ 129.48
pills
3.8 (3)

Haldol

Active ingredient: Haloperidol
10mg 5mg
From $ 251.16
pills
3.9 (5)

Olanzapine

Active ingredient: Olanzapine
2.5mg 5mg 7.5mg
From $ 154.44
pills
4 (5)

Risperdal Current

Active ingredient: Risperidone
2mg 3mg 4mg 1mg
From $ 121.68
pills
3.7 (3)

Seroquel

Active ingredient: Quetiapine
100mg 200mg 25mg 300mg 50mg
From $ 63.96
pills
3.9 (5)

Comparison table: Antipsychotics

Common questions

What should I do if the expected result does not come?

Do not increase the dose independently or stop Risperdal suddenly. The treating psychiatrist may need to review the diagnosis, adherence, dose timing, interactions, substance use, sleep, and the length of treatment. Health Canada guidance from 2023 supports clinical reassessment when symptoms remain uncontrolled or adverse effects limit treatment; the response can differ substantially between individuals.

Which diet, exercise, or habits help or hinder the result?

Regular sleep, moderate physical activity, and a balanced eating pattern can support general health during risperidone treatment. Alcohol and other sedating substances can worsen drowsiness, impaired coordination, and falls. The WHO identified physical activity and metabolic monitoring in 2022 as relevant parts of long-term care for people receiving antipsychotic treatment, including attention to weight and glucose changes.

What should I do after a missed dose?

Take the missed tablet when remembered unless the next scheduled dose is near. In that situation, skip the missed dose and resume the regular schedule; never take two doses together to compensate. The EMA product information from 2024 describes missed-dose management as a reason to avoid unsupervised doubling, especially when sedation or dizziness is possible.

What should I check or discuss with a doctor before starting?

Discuss kidney or liver disease, epilepsy, Parkinsonism, heart rhythm problems, fainting, diabetes, previous medication reactions, pregnancy, and breastfeeding. Provide a complete list of medicines, including metoclopramide, prochlorperazine, antidepressants, sleeping aids, and substances that cause sedation. The FDA prescribing information from 2023 also supports reviewing cardiovascular, metabolic, movement, and prolactin-related risks before and during treatment.

Which symptoms mean stopping and seeing a doctor urgently?

Urgent assessment is needed for high fever with severe muscle stiffness or confusion, a seizure, fainting, severe allergic swelling, uncontrolled movements, or marked difficulty swallowing or breathing. New one-sided weakness, facial drooping, or trouble speaking also requires emergency care. Health Canada product information from 2023 identifies serious neurological, cardiovascular, allergic, and movement-related reactions that should not wait for a routine appointment.

How long does one dose keep working?

An oral risperidone dose contributes to symptom control across the dosing interval prescribed by the clinician, but the clinical effect is not identical to an immediate calming effect. Risperidone and its active metabolite remain in the body for longer than the sensation of drowsiness, so missed doses can still affect treatment stability. EMA pharmacokinetic information from 2024 supports judging the medicine over repeated scheduled doses rather than changing it based on one afternoon or one night.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Customer Feedback on Risperdal

3.7
Based on 3 reviews
Martin, 44 Hamilton Several weeks
Verified
Rating: 3.5 out of 5

Martin, 44 - Hamilton, had taken risperidone tablets at his prescribed dose for several weeks after severe mood and thought disturbances. He reported that sleep became more settled and frightening thoughts reduced, but morning drowsiness made work difficult at first. His clinician adjusted the timing and monitored his response.

Oct 29, 2026
Ben S., 69 Toronto A month
Verified
Rating: 3.5 out of 5

Ben S., 69 - Toronto, used risperidone at his prescribed dose for a month as part of treatment for psychotic symptoms. He felt calmer after the first month, yet noticed stiffness and slower walking. The movement symptoms were discussed at follow-up rather than ignored, and his treatment plan was reviewed.

Nov 15, 2026
Stephen, 69 St. John's Several weeks
Verified
Rating: 4 out of 5

Stephen, 69 - St. John's, found that the tablets, taken at his prescribed dose over several weeks, reduced agitation but experienced increased appetite and gradual weight gain. He felt the treatment helped his daily routine, although the metabolic monitoring and dietary changes became an ongoing part of care.

Oct 18, 2026

Sources

  1. Health Canada (2023). Product information for risperidone and Risperdal.
  2. European Medicines Agency (2024). Summary of Product Characteristics for risperidone.
Get our free app Shop faster and track your orders 3.9 · 514 reviews Install